Investment20 Aug 2025, 09:29 pm
Piramal Pharma Subsidiary Completes USD 190.3 Million Investment in PPL Pharma Inc.
AI Summary
Piramal Pharma Ltd. has announced that its step-down wholly owned subsidiary, Piramal Healthcare Inc., has successfully completed the subscription of 1,903 optionally convertible redeemable preference shares of PPL Pharma Inc., another step-down wholly owned subsidiary of the company. The total value of the investment stands at USD 190,300,000, which is approximately INR 1,626.49 Crore.
Key Highlights
- Piramal Healthcare Inc., a material step-down wholly owned subsidiary of Piramal Pharma Ltd., has invested USD 190.3 million in PPL Pharma Inc.
- The investment is in the form of 1,903 optionally convertible redeemable preference shares of face value of USD 100,000 each.
- PPL Pharma Inc. is a step-down wholly owned subsidiary of Piramal Pharma Ltd.
- The total investment amounts to approximately INR 1,626.49 Crore.
- This investment signifies Piramal Pharma's commitment to strategic growth and expansion.